|
Oncogene Protein v-maf
|
D051256 |
[An oncogene protein that was originally isolated from a spontaneous musculo-aponeurotic FIBROSARCOMA in CHICKEN and shown to be the transforming gene of the avian retrovirus AS42. It is a basic leucine zipper TRANSCRIPTION FACTOR and the founding member of the MAF TRANSCRIPTION FACTORS.
] |
|
Proto-Oncogene Proteins c-maf
|
D051257 |
[Maf proto-oncogene protein is the major cellular homolog of the V-MAF ONCOGENE PROTEIN. It was the first of the mammalian MAF TRANSCRIPTION FACTORS identified, and it is induced in activated T-LYMPHOCYTES and regulates GENETIC TRANSCRIPTION of INTERLEUKIN-4. c-maf is frequently translocated to an immunoglobulin locus in MULTIPLE MYELOMA.
] |
|
Atrial Pressure
|
G09.330.040.600 |
|
|
MafB Transcription Factor
|
D051258 |
[A large maf protein that regulates HINDBRAIN development, contributes to CELL DIFFERENTIATION of MONOCYTES, and interacts with ETS-1 TRANSCRIPTION FACTOR.
] |
|
Bed Conversion
|
N03.349.650.250.080 |
|
|
Health Facility Planning
|
N03.349.650.250 |
|
|
In Situ Hybridization, Fluorescence
|
E05.200.750.600.670.325.350 |
|
|
In Situ Hybridization
|
E05.200.750.600.670.325 |
|
|
MafG Transcription Factor
|
D051259 |
[MafG is a ubiquitously expressed small maf protein that is involved in CELL DIFFERENTIATION of ERYTHROCYTES. It dimerizes with P45 NF-E2 PROTEIN and activates expression of ALPHA-GLOBIN and BETA-GLOBIN.
] |
|
Regulatory-Associated Protein of mTOR
|
D12.776.476.925.500.500 |
|
|
Reticulum
|
A13.869.697 |
|
|
Bencyclane
|
D02.455.426.392.368.284.100 |
|
|
Afatinib
|
D03.633.100.786.188 |
|
|
Bacteriophage Pf1
|
B04.123.370.400.300 |
|
|
Epigen
|
D12.776.467.382.531 |
|
|
MafF Transcription Factor
|
D051260 |
[A small maf protein that forms dimers with NRF1 protein; NRF2 PROTEIN; and P45 NF-E2 PROTEIN. MafF complexes bind Maf recognition elements to regulate tissue-specific GENETIC TRANSCRIPTION.
] |
|
Granulomatosis, Orofacial
|
D051261 |
[A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.
] |
|
Centromere Protein B
|
D12.776.660.235.199 |
|
|
Caves
|
G01.311.169 |
|
|
D-Alanine Transaminase
|
D051263 |
[A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transfer of an amino group between D-Alanine and alpha-ketoglutarate to form PYRUVATE and D-GLUTAMATE, respectively. It plays a role in the synthesis of the bacterial CELL WALL. This enzyme was formerly classified as EC 2.6.1.10.
] |
